Search for: "In Re: Lorazepam & Clorazepate Antitrust Litigation"
Results 1 - 6
of 6
Sorted by Relevance
|
Sort by Date
16 Feb 2009, 7:21 pm
Index not required if produced data is searchable By MWS In re Lorazepam and Clorazepate Antitrust Litig., 2004 WL 77921 (D.D.C. [read post]
6 Feb 2011, 5:31 am
IN RE: LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION was an appeal of a $77 million judgment in an antitrust suit. [read post]
12 Oct 2011, 12:33 pm
Court of Appeals in Washington, D.C. with respect to federal jurisdiction over antitrust class action claims (In re: Lorazepam & Clorazepate Antitrust Litigation, 631 F.3d 537, CCH 2011-1 Trade Cases ¶77,440). [read post]
3 Aug 2010, 8:19 am
” (In re Lorazepam & Clorazepate Antitrust Litigation (D.D.C. 2002) 205 F.R.D. 369, 379; see also In re Insurance Brokerage Antitrust Litigation (D.N.J., Feb. 16, 2007, MDL No. 1663, No. 04-5184(FSH)) 2007 U.S. [read post]
25 Jul 2017, 6:28 am
Circuit’s Lorazepam & Clorazepate Antitrust Litigation framework (In Re Herman Brewer, July 21, 2017, Ginsburg, D.). [read post]
13 Mar 2009, 2:00 am
When the District of Columbia was posed with this issue in In re Lorazepam and Clorazepate Antitrust Litig., the court stated that so long as the data on the CDs is readable and searchable, no index is required. [read post]
